CN102228517A - Plantain seed extract and application thereof - Google Patents
Plantain seed extract and application thereof Download PDFInfo
- Publication number
- CN102228517A CN102228517A CN 201110172511 CN201110172511A CN102228517A CN 102228517 A CN102228517 A CN 102228517A CN 201110172511 CN201110172511 CN 201110172511 CN 201110172511 A CN201110172511 A CN 201110172511A CN 102228517 A CN102228517 A CN 102228517A
- Authority
- CN
- China
- Prior art keywords
- semen plantaginis
- extract
- plantain seed
- diabetes
- seed extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Plantain seed extract and application thereof. The Plantain seed extract is acquired by reflux extraction of Plantain seed with 2-6 volume times of 60-90vol% ethanol aqueous solution 2-6 times. The Plantain seed extract contains acteoside, isoacteoside, geniposidic acid, ferulic acid, and Cheqiansu A and Cheqiansu B. In-vivo experiments show that the Plantain seed extract provided by the invention can promote glucose consumption and has lower toxicity to cells; and simultaneously in-vitro experiments show that the Plantain seed extract can significantly increase serum insulin level and reduce fasting blood-glucose level, presents good medicinal value in treatment of diabetes; therefore, the Plantain seed extract can be used in the preparation of pharmaceutical medicaments for treating diabetes singly or together with a pharmaceutically acceptable composition composed of a drug carrier.
Description
Technical field
The present invention relates to a kind of Semen Plantaginis extract and application thereof, belong to technical field of Chinese medicines.
Background technology
Current, diabetes have become one of three big chronic diseases of serious harm modern humans health.Diabetes mainly show as and have a good appetite, drinking a lot of water, and it is many to urinate, and the symptom of " three-many-one-little " of losing weight simultaneously along with the prolongation of the time of falling ill, can cause the complication of multiple tissue, organ.The medicine that is used for the treatment of diabetes at present mainly contains sulphanylureas, meglitinide, biguanides, thiazolidine dione compounds and alpha-glucosidase inhibitor etc.These medicines have certain therapeutical effect to diabetes, but also are accompanied by simultaneously many side effect, as gastral untoward reaction and certain Liver and kidney toxicity etc.Simultaneously because diabetes are results that the metabolism of several systems gets muddled in the body, it is the chronic lifelong participation disease of many reasons, patient and government have paid economical and spiritual great cost in the process of long-term treatment, and the new method of therefore seeking the treatment diabetes in Chinese medicine has bigger social benefit.
Semen Plantaginis is a conventional Chinese medicine, " Chinese pharmacopoeia (2010 editions) is with the dry mature seed of Plantaginaceae Plantago plant Herba Plantaginis Plantago asiatica L. or the Plantago depressa Willd Plantago depressa Willd. Ji Yuan as Semen Plantaginis, has clearing away heat and promoting diuresis, eliminating dampness by diuresis is treating stranguria, the effect such as eliminate the phlegm that makes eye bright is used for the treatment of acute glomerulonephritis, cough with asthma and icterohepatitis etc. traditionally.But Semen Plantaginis also other Chinese medicines of compatibility is used, and for example the compatibility Semen Plantaginis plays the effect of clearing away heat-damp and promoting diuresis in the compound recipe Decoction of Gentiana for Purging the Liver-fire.The alcohol extract of the mutation hair Plantago depressa Willd of discovered in recent years Plantaginaceae plant Plantago depressa Willd (P.depressa var.montata Kitag.) has the effect that certain blood sugar lowering is transferred blood fat to diabetic mice due to the alloxan, its chemical constituent is studied the back find, be mainly ursolic acid, oleanolic acid, apigenin, luteolin, catalpol, martynoside, Homoplantaginin, dinatin etc.Other has researcher to find, the methanolic extract of Herba Plantaginis (P.asiatica L.) also has inhibitory action to the formation of glycosylation dead end product, demonstrate its potential treating diabetes effect, and to propose glycosylation mortifier main in this extract be Big Semen Plantaginis glycosides (plantamajoside).Simultaneously, the seed shell of Psyllium (P.ovata) has relieving constipation, cholesterol reducing, improves the blood sugar level of diabetics, and has been developed to nutriment.
Summary of the invention
The purpose of this invention is to provide a kind of Semen Plantaginis extract and application thereof.
Described Semen Plantaginis extract is to be that 60～90% ethanol water reflux, extract, obtains for 2～6 times by Semen Plantaginis through the volume fraction of 2～6 times of volumes, contains acteoside, different acteoside, Geniposidic acid, ferulic acid, the plain A of Herba Plantaginis and the plain B of Herba Plantaginis.
Further, described Semen Plantaginis extract is to be that 70～80% ethanol water reflux, extract, obtains for 3～5 times by Semen Plantaginis through the volume fraction of 3～5 times of volumes.
Further, described Semen Plantaginis extract is to be that 75% ethanol water reflux, extract, obtains for 4 times by Semen Plantaginis through the volume fraction of 4 times of volumes.
Described Semen Plantaginis is recommended as the dry mature seed of Plantaginaceae plant Herba Plantaginis (Plantago asiatica L.) and/or Plantago depressa Willd (Plantago depressa Willd.).
Described Semen Plantaginis recommends to be ground into the granule that diameter is less than or equal to 6mm.
The application of described Semen Plantaginis extract in preparation treatment preparations for diabetes.
The application of the compositions that described Semen Plantaginis extract and pharmaceutically acceptable pharmaceutical carrier are formed in preparation treatment preparations for diabetes.
Described diabetes are I type and/or type ii diabetes.
Described pharmaceutical dosage forms can be any pharmaceutically useful dosage form, and these dosage forms comprise: tablet, sugar coated tablet, film coated tablet, enteric coated tablet, capsule, hard capsule, soft capsule, oral liquid, suck agent, granule, electuary, pill, powder, unguentum, sublimed preparation, suspensoid, powder, solution, injection, suppository, ointment, plaster, cream, spray, drop, patch; The preferred oral dosage form, as: capsule, tablet, oral liquid, granule, pill, powder, sublimed preparation, unguentum etc.Described peroral dosage form can contain excipient commonly used, such as binding agent, filler, diluent, tablet agent, lubricant, disintegrating agent, coloring agent, flavoring agent and wetting agent, can carry out coating to tablet in case of necessity.Suitable filler comprises cellulose, mannitol, lactose and other similar filler; Suitable disintegrating agent comprises starch, polyvinylpyrrolidone and starch derivatives, for example sodium starch glycollate; Suitable lubricant comprises, for example magnesium stearate.The acceptable wetting agent of appropriate drug comprises sodium lauryl sulphate.
The present invention utilizes the HepG2 cell to carry out the extracorporeal glucose consumption test, the type i diabetes mice that utilizes alloxan to cause simultaneously, the type i diabetes mice that streptozotocin causes, streptozotocin is increased the type ii diabetes rat that the fat feedstuff causes and is carried out effect experiment in the body, the result shows: can promote the consumption of glucose during Semen Plantaginis extract provided by the invention is tested in vivo, and the toxicity of pair cell is low, simultaneously in vitro tests, can obviously improve serum insulin levels, reduce fasting blood glucose level, demonstrate the medical value of good curing diabetes (I type and II type).
Description of drawings
The finger printing that the Semen Plantaginis extract that Fig. 1 obtains for embodiment 1 obtains under positive ion mode.
The finger printing that the Semen Plantaginis extract that Fig. 2 obtains for embodiment 1 obtains under negative ion mode.
The mass spectrum that the Semen Plantaginis extract that Fig. 3 obtains for embodiment 1 obtains under positive ion mode.
The mass spectrum that the Semen Plantaginis extract that Fig. 4 obtains for embodiment 1 obtains under negative ion mode.
The specific embodiment
Below in conjunction with embodiment the present invention is done further detailed, complete explanation.
Embodiment 1
Remove sandstone and impurity, Semen Plantaginis is pulverized to the granule of 4mm, sieve,, reclaim solvent behind the extracting liquid filtering, use the normal saline suspendible before the use to dried with 75% alcohol reflux of 4 times of volumes 4 times.
It is an amount of to take by weighing the Semen Plantaginis extract sample, (V: V) aqueous solution of formic acid and methanol are that 90: 10 blended solution is dissolved in the volumetric flask by volume with 0.1%, be diluted to scale, shake up, make every 1mL solution and contain the 1g sample, and utilize Ultra Performance Liquid Chromatography-GC-MS (UPLC-MS) to analyze, analysis condition is as follows:
Chromatographic condition: Waters, Acquity UPLC BEH C
18(50 * 2.1mm) chromatographic columns; (V: the V) aqueous solution of formic acid, Mobile phase B are methanol to mobile phase A mutually in order to contain 0.1% mutually; Flow velocity is 0.3min; Column temperature is 40 ℃; Sample size is 2 μ L; Detecting pattern is the monitoring of negative ions full scan.
The mass spectrum condition: adopt electric spray ion source, when cation full scan detecting pattern carried out data acquisition, ion source temperature was 120 ℃; The temperature of desolvating is 300 ℃; Nitrogen is for desolvating and taper hole gas, and flow velocity is respectively 500L/h and 50L/h; Capillary voltage is 2.2 kilovolts; Taper hole voltage is 23 volts.When anion full scan detecting pattern carried out data acquisition, ion source temperature was 120 ℃; The temperature of desolvating is 300 ℃; Nitrogen is for desolvating and taper hole gas, and flow velocity is respectively 500L/h and 50L/h; Capillary voltage is 2.5 kilovolts; Taper hole voltage is 32 volts.
Fig. 1 is the finger printing that the Semen Plantaginis extract that obtains obtains under positive ion mode, wherein main chromatographic peak is accredited as ferulic acid, the plain B of Herba Plantaginis, the plain A of Herba Plantaginis and acteoside, Fig. 2 is the finger printing that the Semen Plantaginis extract that obtains obtains under negative ion mode, and wherein main chromatographic peak is accredited as Geniposidic acid, the plain A of Herba Plantaginis, acteoside and different acteoside; Fig. 3 is the mass spectrum that the Semen Plantaginis extract that obtains obtains under positive ion mode, and Fig. 4 is the mass spectrum that the Semen Plantaginis extract that obtains obtains under negative ion mode; In conjunction with Fig. 1 to Fig. 4 as seen: contain acteoside, different acteoside, Geniposidic acid, ferulic acid, the plain A of Herba Plantaginis and the plain B of Herba Plantaginis in the Semen Plantaginis extract that obtains.
Embodiment 2
With the HepG2 cell inoculation in 96 orifice plates, treat that cell grows to 60% and merges, change the culture fluid of the variable concentrations Semen Plantaginis extract that contains 0.2% bovine serum albumin (BSA), behind the incubation 24h, detect the residual amount of glucose in the training liquid, be calculated as follows the glucose consumption rate of each porocyte of 24h.
Glucose consumption rate=(experimental port 0h measured value-experimental port 24h measured value)/(control wells 0h measured value-control wells 24h measured value) * 100%.
Table 1 Semen Plantaginis extract is to the facilitation of HepG2 cell glucose metabolism
Annotate: the positive medicine of metformin.
*P＜0.05,
*P＜0.01,
* *P＜0.001 is compared with control wells.
By table 1 as seen: Semen Plantaginis extract demonstrates the facilitation to the glucose metabolism of HepG2 cell.
Embodiment 3
When the off-test of HepG2 grape cell sugar consumption, culture fluid to be measured is shifted out, change the culture fluid that contains 0.5g/LMTT and continue to hatch 4h, then to the greatest extent with culture fluid, blot, every hole adds the 200l dimethyl sulfoxine again, survey absorbance in the 570nm place on the rearmounted microplate reader of mixing, be calculated as follows the HepG2 cell survival rate: cell survival rate=experimental port measured value/control wells measured value * 100%.
Table 2 Semen Plantaginis extract is to the toxicity of HepG2 cell
Annotate: the positive medicine of metformin.
* *P＜0.001 is compared with control wells.
By table 2 as seen: with respect to the positive control drug metformin, Semen Plantaginis extract is less to the toxicity of HepG2 cell, demonstrates better safety.
Embodiment 4
Select healthy male mice for use, (22 ± 2) g is divided into normal group and modeling group at random, modeling group tail vein injection alloxan 48mg/kg.After 3 days, mice fasting 12h, freely drink water, fasting blood glucose level with the determination of glucose oxidase mice, the screening blood glucose value enters experiment greater than the mice of 11.1mmol/L, and be divided into model group and Semen Plantaginis extract group, wherein Semen Plantaginis extract group administration every day Semen Plantaginis extract 300mg/kg.In two weeks of continuous oral gastric infusion, after administration finishes, measure the mice fasting blood sugar.Experimental data is carried out variance analysis, and the result represents with x ± s.
The blood sugar reducing function of the type i diabetes mice that table 3 Semen Plantaginis extract causes alloxan
| Normal group | Model group | The Semen Plantaginis extract group | |
| Fasting blood sugar (mmol/L) | 4.94±0.85 | 19.40±5.12 ### | 10.30±5.10 ** |
Annotate:
###P＜0.001 is compared with normal group;
*P＜0.01 is compared with model group.
By table 3 as seen: compare with normal group, model group mice fasting blood sugar significantly raises, and type i diabetes model modeling success is described.Simultaneously, compare with model group, the fasting blood sugar of Semen Plantaginis extract group significantly reduces, and illustrates that Semen Plantaginis extract has the effect of significant reduction fasting glucose.
Embodiment 5
Select healthy male mice for use, (22 ± 2) g is divided into normal group and modeling group at random, and modeling group lumbar injection streptozotocin 150mg/kg cuts tail and surveys random blood sugar behind the 48h, and the mice that the screening blood glucose value surpasses 10.1mmol/L enters experiment.With normal components is normal control group and normal administration group, and the modeling component is model group and model administration group.Normal administration group and model administration group administration every day Semen Plantaginis extract 300mg/kg.In 4 weeks of continuous oral gastric infusion, after administration finishes, measure mice serum insulin and fasting blood sugar.Experimental data is carried out variance analysis, and the result represents with x ± s.
The blood sugar reducing function of the type i diabetes mice that table 4 Semen Plantaginis extract causes streptozotocin
| The normal control group | Normal administration group | Model group | Model administration group | |
| Serum insulin value (IU/mL) | 24.56±4.21 | 31.97±7.03 # | 13.50±2.22 ### | 17.21±3.29 * |
| Fasting blood sugar (mmol/L) | 5.31±0.27 | 5.06±0.75 | 29.94±5.18 ### | 23.32±6.62 * |
Annotate:
#P＜0.05,
###P＜0.001 is compared with normal group;
*P＜0.05 is compared with model group.
By table 4 as seen: compare with the normal control group, model group mice fasting blood sugar significantly raises, and type i diabetes model modeling success is described.Simultaneously, compare with model group, Semen Plantaginis extract has significant rising serum insulin and reduces the effect of fasting glucose.Compare with the normal control group, normal administration group can make serum insulin raise, and blood glucose is slightly reduced, and the avirulence phenomenon takes place simultaneously, has shown the safety of Semen Plantaginis extract.
Embodiment 6
Select healthy male wistar rat for use, (200 ± 20) g, be divided into normal group and high fat group (88% normal diet+10% Adeps Sus domestica+2% cholesterol) at random, feed behind the 3w, high fat group lumbar injection streptozotocin 35mg/kg cuts tail and surveys random blood sugar after five days, the rat that the screening blood glucose value surpasses 16.7mmol/L enters experiment, and be divided into model group and Semen Plantaginis extract group, wherein Semen Plantaginis extract group administration every day Semen Plantaginis extract 150mg/kg.In 4 weeks of continuous oral gastric infusion, after administration finishes, measure rat blood serum insulin and fasting blood sugar.Experimental data is carried out variance analysis, and the result represents with x ± s.
Table 5 Semen Plantaginis extract is to the blood sugar reducing function of type ii diabetes rat
| Normal group | Model group | The Semen Plantaginis extract group | |
| Serum insulin value (IU/mL) | 44.48±12.51 | 17.85±3.78 ### | 25.31±5.52 ** |
| Fasting blood sugar (mmol/L) | 10.12±0.67 | 26.21±1.61 ### | 25.17±5.55 |
Annotate:
###P＜0.001 is compared with normal group;
*P＜0.01 is compared with model group.
By table 5 as seen: compare with normal group, model group rat fasting blood-glucose value significantly raises, and type ii diabetes model modeling success is described.Simultaneously, compare with model group, Semen Plantaginis extract has significant rising serum insulin and reduces the effect of fasting glucose.
Claims (8)
1. Semen Plantaginis extract, it is characterized in that: be to be that 60～90% ethanol water reflux, extract, obtains for 2～6 times through the volume fraction of 2～6 times of volumes, contain acteoside, different acteoside, Geniposidic acid, ferulic acid, the plain A of Herba Plantaginis and the plain B of Herba Plantaginis by Semen Plantaginis.
2. Semen Plantaginis extract according to claim 1 is characterized in that: be to be that 70～80% ethanol water reflux, extract, obtains for 3～5 times by Semen Plantaginis through the volume fraction of 3～5 times of volumes.
3. Semen Plantaginis extract according to claim 2 is characterized in that: be to be that 75% ethanol water reflux, extract, obtains for 4 times by Semen Plantaginis through the volume fraction of 4 times of volumes.
4. Semen Plantaginis extract according to claim 1 is characterized in that: described Semen Plantaginis is the dry mature seed of Plantaginaceae plant Herba Plantaginis and/or Plantago depressa Willd.
5. Semen Plantaginis extract according to claim 1 is characterized in that: described Semen Plantaginis powder is broken into the granule that diameter is less than or equal to 6mm.
6. the application of the described Semen Plantaginis extract of claim 1 in preparation treatment preparations for diabetes.
7. the application of the compositions of described Semen Plantaginis extract of claim 1 and pharmaceutically acceptable pharmaceutical carrier composition in preparation treatment preparations for diabetes.
8. according to claim 6 or 7 described application, it is characterized in that: described diabetes are I type and/or type ii diabetes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110172511 CN102228517B (en) | 2011-06-23 | 2011-06-23 | Plantain seed extract and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110172511 CN102228517B (en) | 2011-06-23 | 2011-06-23 | Plantain seed extract and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102228517A true CN102228517A (en) | 2011-11-02 |
| CN102228517B CN102228517B (en) | 2013-01-16 |
Family
ID=44841149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110172511 Active CN102228517B (en) | 2011-06-23 | 2011-06-23 | Plantain seed extract and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102228517B (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102151281A (en) * | 2011-01-24 | 2011-08-17 | 中国药科大学 | Flavonoid compound for preventing and treating diabetes and medicament application thereof |
| CN105796674A (en) * | 2014-12-31 | 2016-07-27 | 上海中医药大学 | Traditional Chinese medicine composition for preventing and treating metabolic syndrome |
| CN106176777A (en) * | 2016-07-14 | 2016-12-07 | 天津中医药大学 | The new application of rhodioside and be used for treating atherosclerotic compositions |
| CN106317140A (en) * | 2015-06-29 | 2017-01-11 | 上海中医药大学 | Novel crystal form of geniposidic acid, and preparation method and application thereof |
| CN113384622A (en) * | 2021-07-27 | 2021-09-14 | 上海中医药大学 | Application of semen plantaginis extract in preparing medicine for treating myocardial hypertrophy |
| CN113461749A (en) * | 2021-08-13 | 2021-10-01 | 许昌学院 | Method for extracting and preparing geniposide from plantago seeds |
| CN115856108A (en) * | 2022-08-31 | 2023-03-28 | 广东一方制药有限公司 | Construction method and identification method of fingerprint of plantain herb traditional Chinese medicine formula granules |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102050787A (en) * | 2009-11-09 | 2011-05-11 | 上海中医药大学 | Guanidine derivatives and preparation, medicinal composition and application in preparation of medicaments for treating metabolic syndromes |
-
2011
- 2011-06-23 CN CN 201110172511 patent/CN102228517B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102050787A (en) * | 2009-11-09 | 2011-05-11 | 上海中医药大学 | Guanidine derivatives and preparation, medicinal composition and application in preparation of medicaments for treating metabolic syndromes |
Non-Patent Citations (2)
| Title |
|---|
| 《上海中医药杂志》 20090831 耿放等 车前子与车前草利尿作用研究 72-74 第43卷, 第08期 * |
| 《中国中药杂志》 20050831 吴斐华等 毛平车前降血糖调血脂作用的研究 1179-1183 1-8 第30卷, 第15期 * |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102151281A (en) * | 2011-01-24 | 2011-08-17 | 中国药科大学 | Flavonoid compound for preventing and treating diabetes and medicament application thereof |
| CN105796674A (en) * | 2014-12-31 | 2016-07-27 | 上海中医药大学 | Traditional Chinese medicine composition for preventing and treating metabolic syndrome |
| CN105796674B (en) * | 2014-12-31 | 2020-08-07 | 上海中医药大学 | Traditional Chinese medicine composition for preventing and treating metabolic syndrome |
| CN106317140A (en) * | 2015-06-29 | 2017-01-11 | 上海中医药大学 | Novel crystal form of geniposidic acid, and preparation method and application thereof |
| CN106317140B (en) * | 2015-06-29 | 2020-12-04 | 上海中医药大学 | Novel crystal form of geniposide and preparation method and application thereof |
| CN106176777A (en) * | 2016-07-14 | 2016-12-07 | 天津中医药大学 | The new application of rhodioside and be used for treating atherosclerotic compositions |
| CN113384622A (en) * | 2021-07-27 | 2021-09-14 | 上海中医药大学 | Application of semen plantaginis extract in preparing medicine for treating myocardial hypertrophy |
| CN113461749A (en) * | 2021-08-13 | 2021-10-01 | 许昌学院 | Method for extracting and preparing geniposide from plantago seeds |
| CN113461749B (en) * | 2021-08-13 | 2023-03-14 | 许昌学院 | Method for extracting geniposide from plantain seeds |
| CN115856108A (en) * | 2022-08-31 | 2023-03-28 | 广东一方制药有限公司 | Construction method and identification method of fingerprint of plantain herb traditional Chinese medicine formula granules |
| CN115856108B (en) * | 2022-08-31 | 2024-05-03 | 广东一方制药有限公司 | Construction method and identification method of fingerprint of plantain herb traditional Chinese medicine formula particles |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102228517B (en) | 2013-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102228517B (en) | Plantain seed extract and application thereof | |
| Herrera-Arellano et al. | Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial | |
| CN106220701B (en) | triterpene compound and preparation method and application thereof | |
| CN103536635A (en) | Preparation method of holothuria nobilis and application thereof in treatment of diabetes mellitus | |
| CN102091083A (en) | Petroleum ether extract of traditional Chinese medicine for preventing and treating glucose and lipid metabolic disturbance and preparation method thereof | |
| CN105169105A (en) | Chinese medicinal preparation having functions of preventing tumors, nourishing yin and stomach and enhancing immunity and preparation method thereof | |
| CN101095720B (en) | Method for preparing total salvianolic acid and the application in the preventing and treating of diabetes and the complication thereof | |
| CN100443498C (en) | Use of anti-inflammatory medicine for scheelite total saponin and its saponin compound | |
| CN101601780A (en) | The application of Chinese violet in anti-diabetic and control correlated metabolism diseases | |
| CN102309542A (en) | Orthosiphon n-butanol fraction medicine for treating chronic nephritis and preparation method thereof | |
| CN102225095B (en) | Effective fraction of plantain seeds as well as preparation method and application thereof | |
| CN102579530A (en) | Preparation method of aralia taibaiensis total saponin having diabetes mellitus resisting effect and medicament | |
| CN107266464B (en) | A kind of rhizoma alismatis decoction extract and its application | |
| CN108524811A (en) | Reduce uric acid, cholesterol, three high Chinese medicine compositions and its preparation method for the treatment of | |
| CN108392506A (en) | The extracting method and pharmaceutical composition of a kind of wilsonii activity extract and its application | |
| CN105535070B (en) | The pharmaceutical composition and its preparation method and application for treating diabetes | |
| CN103054932B (en) | Principal columns of a hall tree extract is preparing the application in treating Gastric Ulcer Treatment | |
| CN104721467A (en) | Traditional Chinese medicine composition for treating diabetic nephropathy and application thereof | |
| KR100473530B1 (en) | Composition containing an extract of sopungsungi-won crude drug complex for preventing and treating diabetes mellitus | |
| CN102526387B (en) | Medicinal composition for treating early-stage diabetic foot and preparation method thereof | |
| CN104042928B (en) | A kind of pharmaceutical composition for treating diabetes and its production and use | |
| CN101249129B (en) | Chinese medicine extract combination and medicine use thereof | |
| KR20200053703A (en) | The composition for anti-obesity and anti-diabets, comprising the extract of aralia excelsa | |
| CN115040476B (en) | Compound blood pseudo-ginseng hypoglycemic oral liquid as well as preparation method and application thereof | |
| CN110314160A (en) | Berbamine prevents and treats the application in medicine for treating diabetic nephropathy in preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |